Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/s10434-007-9543-0
Annals of Surgical Oncology 14:3352-3358 (2007)
© 2007 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Javid, S. H.
Right arrow Articles by Golshan, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Javid, S. H.
Right arrow Articles by Golshan, M.

Original Article

Breast MRI Wire-Guided Excisional Biopsy: Specimen Size as Compared to Mammogram Wire-Guided Excisional Biopsy and Implications for Use

Sara H. Javid, MD1, Joseph W. Carlson, MD, PhD2, Judy E. Garber, MD3, Robyn L. Birdwell, MD4, Susan Lester, MD, PhD2, Stuart Lipsitz, ScD1 and Mehra Golshan, MD1

1 Department of Surgery, Brigham and Women’s Hospital, Boston, MA, USA
2 Pathology Brigham and Women’s Hospital, Boston, MA, USA
3 Department of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical School, Boston, MA, USA
4 Department of Radiology, Brigham and Women’s Hospital, Boston, MA, USA

Correspondence: Address correspondence and reprint requests to: Mehra Golshan, MD; E-mail: mgolshan{at}partners.org

Background: Breast magnetic resonance imaging (MRI) has been implemented as a screening tool for early detection and as a diagnostic test in the management of breast cancer. Lesions identified by MRI but not amenable to conventional biopsy techniques require MRI wire-guided excisional biopsy (MRIbx). We hypothesized that more tissue would be resected with MRIbx compared to Mammobx. We also sought to evaluate factors that might predict the presence of breast cancer in patients undergoing MRIbx.

Methods: We reviewed consecutive cases of breast MRIbx from 2004 to 2006 performed by seven surgeons. MRI was performed in patients with either a synchronous breast cancer or significant risk factors. Lesions visualized only by MRI underwent diagnostic MRIbx. The control group was comprised of consecutive cases that underwent diagnostic Mammobx during the same time period. The volumes of tissue resected, overall and by pathologic outcome, were compared.

Results: Seventy-one patients, with a mean age of 48, underwent MRIbx. Eleven (15.5%) invasive breast cancers and eight cases (11.3%) of ductal carcinoma in situ (DCIS) were identified. The median volume of tissue resected was significantly greater than that in the Mammobx group (28.8 cm3 vs 21.1 cm3, respectively). DCIS-containing MRIbx specimens were significantly larger than benign or invasive cancer-containing specimens. There was no significant overall association between either the indication for MRIbx or the size of the MRI lesion and the frequency of cancer.

Conclusions: In patients undergoing breast MRIbx, 27% were found to have DCIS or invasive breast cancer. MRIbx was associated with significantly larger specimen volumes than Mammobx.

Key Words: Breast MRI • Invasive breast cancer • Wire localized biopsy






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society of Surgical Oncology.